739PQuality of life (QoL) in patients with metastatic pancreatic cancer receiving first-line Nab-paclitaxel/gemcitabine chemotherapy: Results of the large QoL study AIO-QoliXane/PARAGON. (23rd October 2018) - Schönherr, C; Götze, T O; zur Hausen, G; Reichart, A; Pauligk, C; Schlag, R; Siegler, G M; Dörfel, S; Aldaoud, A; Hahn, L; Schubert, J; Zahn, M-O; et al.